Markets trim early gains; Nifty holds 8,400

Profit taking in private banks and IT majors Infosys and TCS capped upside gains

SI Reporter Mumbai
Last Updated : Nov 18 2014 | 9:36 AM IST
Benchmark share indices opened marginally higher to hit fresh record highs but further upside was capped because of profit taking in select private banks and IT majors.

At 9:30AM, the 30-share Sensex was up 16 points at 28,194 and the 50-share Nifty was down 4 points at 8,426.
 
Meanwhile, foreign institutional investors were net buyers in Indian equities worth Rs 656.37crore on Monday, as per provisional stock exchange data.
 

Also Read

Japanese shares have rebounded from yesterday's slump boosted by deal activity worth $100 billion in the US and anticipation of European  monetary stimulus. Nikkei has gained around 1.6%.
 
Meanwhile, Chinese shares are trading weak after the launch of direct connect project which connects stock markets of China and Honk Kong. Hang Seng is trading down 0.4% while Shanghai Composite index has lost 0.2%.
 
US markets closed mixed with S&P 500 ending at record closing high boosted by deal activity worth $100 billion dollars. The Dow Jones industrial average ended flat at 17,648, the S&P 500 closed at 2,041.32, a record closing high. Nasdaq closed lower by 0.3%  dragged by losses in Google and Gilead.
 
The BSE Capital Goods Index was the top gainer up 0.9% followed by Oil & Gas and Power indices among others. BSE Consumer Durables index was the sole loser down 0.1%.

Among the index heavyweights Reliance Industries was up nearly 1% while ITC was up 0.6% contributing the most to the Sensex gains.

SBI was up 1%. The bank reported robust Q2 earnings. Further, reports suggest that in order to make gains from rising stock market it has expanded its list of equities for investments to go beyond the National Stock Exchange's Nifty 50 index scrips.

Capital goods stocks rebounded today with L&T and BHEL up 1% each.

Sun Pharma was up 0.5%. The company has recalled about 68,000 bottles of its anti-depressant venlafaxine hydrochloride, from the US market. The company withdrew the drugs, manufactured in its Halol unit in India, after they failed to dissolve properly, said the US Food and Drug Administration.

In the broader market, the BSE Mid-cap index and the Small-cap index were up 0.6% each.

Market breadth was strong with 1,120 gainers and 551 losers on the BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 18 2014 | 9:30 AM IST

Next Story